Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-13-002185
Filing Date
2013-03-05
Accepted
2013-03-05 13:50:51
Documents
12
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2213009z10-k.htm 10-K 969584
2 EX-23.1 a2213009zex-23_1.htm EX-23.1 5583
3 EX-31.1 a2213009zex-31_1.htm EX-31.1 7876
4 EX-31.2 a2213009zex-31_2.htm EX-31.2 7908
5 EX-32.1 a2213009zex-32_1.htm EX-32.1 5330
12 G583866.JPG g583866.jpg GRAPHIC 44364
  Complete submission text file 0001047469-13-002185.txt   7422480

Data Files

Seq Description Document Type Size
6 EX-101.INS rigl-20121231.xml EX-101.INS 989761
7 EX-101.SCH rigl-20121231.xsd EX-101.SCH 66389
8 EX-101.CAL rigl-20121231_cal.xml EX-101.CAL 63014
9 EX-101.LAB rigl-20121231_lab.xml EX-101.LAB 1055168
10 EX-101.PRE rigl-20121231_pre.xml EX-101.PRE 505788
11 EX-101.DEF rigl-20121231_def.xml EX-101.DEF 299786
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 13665038
SIC: 2834 Pharmaceutical Preparations